Here are the key details: Start date: July 1, 2026 End date: December 31, 2027 (unless extended by Congress) Eligible medications: FDA-approved anti-obesity medications, including Wegovy (semaglutide 2.4 mg) and Zepbound (tirzepatide) Patient cost: Flat $50 per month copay Deductible: Waived - the Part D deductible does not apply to medications obtained through this program Prior authorization: Required by most Part D plans, but criteria are standardized under the program The bridge structure is important to understand
Unravel the debate of biotin vs B12, as our meticulously crafted formulations provide clarity, allowing you to make informed decisions for your unique wellness journey
The treatment becomes sustainable rather than something people try for a few months and then stop because they feel terrible
Understanding the actual mechanisms behind GLP-1 therapy helps patients and clinicians set realistic expectations for treatment outcomes and recognize that successful weight management with these agents requires active participation in dietary modifications alongside medication use
More specifically, she said I needed to first go on the website, qualify for the WeightWatchers Clinic program and get a virtual consultation (with a $49 membership fee) before I could ask about pricing
In addition to writing for Everyday Health, her work has bee...